Genital candidiasis
Abstract
Vulvovaginal candidiasis (vaginal thrush) remains an extremely common clinical problem, with both over- and under-diagnosis and unreliable self-diagnosis. Little progress has been made in providing diagnostic tests, and consequently inappropriate antifungal therapy is common. New genetic susceptibility mechanisms are emerging. No new antifungal drug regimens have recently appeared; accordingly, therapeutic recommendations are unchanged. Antifungal drug resistance fortunately remains rare.
Keywords: azole antifungals, candidosis, C. albicans, C. glabrata, genetic susceptibility, vaginal thrush, vulvovaginal candidiasis
To access this article, please choose from the options below
PII: S1357-3039(10)00048-4
doi:10.1016/j.mpmed.2010.02.001
© 2010 Elsevier Ltd. All rights reserved.

